Literature DB >> 25858868

Cystatin C: a kidney function biomarker.

Anna Onopiuk1, Anna Tokarzewicz1, Ewa Gorodkiewicz2.   

Abstract

Renal function is essential for homeostasis. The kidneys play important pleiotropic roles including removal of metabolic waste products and maintenance of water-electrolyte balance and blood pressure. Early diagnosis of renal dysfunction and institution of appropriate therapy are vital to survival. Unfortunately, common indicators of renal function lack necessary sensitivity and specificity. Recent evidence has, however, suggested that cystatin C (cysC) may be useful as a marker for glomerular filtration. CysC is a protein belonging to a group of cysteine proteases inhibitors produced primarily by nucleated cells. Due to low molecular weight and positive pI, it is easily filtered. Moreover, its serum concentration is independent of gender, age, or muscle mass, i.e., typical confounders in assessing glomerular filtration rate (GFR). This chapter discusses the structure and biologic function of cysC, its role as an indicator of GFR, and the most frequently used methods for its determination.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cystatin C; GFR; Kidney diseases; SPRI biosensor

Mesh:

Substances:

Year:  2015        PMID: 25858868     DOI: 10.1016/bs.acc.2014.11.007

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  34 in total

1.  Forced Intercalation (FIT)-Aptamers.

Authors:  Sasha B Ebrahimi; Devleena Samanta; Ho Fung Cheng; Levy I Nathan; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2019-08-23       Impact factor: 15.419

2.  Serum cystatin c is not superior to serum creatinine for early diagnosis of contrast-induced nephropathy in patients who underwent angiography.

Authors:  Qian Xu; Na-Na Wang; Shao-Bin Duan; Na Liu; Rong Lei; Wei Cheng; Shun-Ke Zhou
Journal:  J Clin Lab Anal       Date:  2016-11-29       Impact factor: 2.352

3.  MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2- Metastatic Breast Cancer.

Authors:  Maura N Dickler; Sara M Tolaney; Hope S Rugo; Javier Cortés; Véronique Diéras; Debra Patt; Hans Wildiers; Clifford A Hudis; Joyce O'Shaughnessy; Esther Zamora; Denise A Yardley; Martin Frenzel; Andrew Koustenis; José Baselga
Journal:  Clin Cancer Res       Date:  2017-05-22       Impact factor: 12.531

4.  The discrepancy between serum creatinine and cystatin C can predict renal function after treatment for postrenal acute kidney injury: multicenter study and pooled data analysis.

Authors:  Masahiro Matsuki; Toshiaki Tanaka; Takeshi Maehana; Yuki Kyoda; Koji Ichihara; Kohei Hashimoto; Masahiro Yanase; Masanori Matsukawa; Hideki Adachi; Satoshi Takahashi; Naoya Masumori
Journal:  Clin Exp Nephrol       Date:  2017-03-03       Impact factor: 2.801

5.  Endogenous Peptide Inhibitors of HIV Entry.

Authors:  Mirja Harms; Manuel Hayn; Fabian Zech; Frank Kirchhoff; Jan Münch
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Nested case-control study reveals increased levels of urinary proteins from human kidney toxicity panels in women predicted to develop preeclampsia.

Authors:  Yamile Lopez-Hernandez; Jorge Alejandro Saldivar-Nava; Idalia Garza-Veloz; Ivan Delgado-Enciso; Laura Elia Martinez-de-Villarreal; Patricia Yahuaca-Mendoza; Iram Pablo Rodriguez-Sanchez; Laura Lopez-Gilibets; Jorge Issac Galvan-Tejada; Carlos Eric Galvan-Tejada; Jose Maria Celaya-Padilla; Margarita L Martinez-Fierro
Journal:  Int Urol Nephrol       Date:  2016-08-29       Impact factor: 2.370

Review 7.  The gut microbiome, diet, and links to cardiometabolic and chronic disorders.

Authors:  Judith Aron-Wisnewsky; Karine Clément
Journal:  Nat Rev Nephrol       Date:  2015-11-30       Impact factor: 28.314

Review 8.  Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values.

Authors:  Kuldeep Dhama; Shyma K Latheef; Maryam Dadar; Hari Abdul Samad; Ashok Munjal; Rekha Khandia; Kumaragurubaran Karthik; Ruchi Tiwari; Mohd Iqbal Yatoo; Prakash Bhatt; Sandip Chakraborty; Karam Pal Singh; Hafiz M N Iqbal; Wanpen Chaicumpa; Sunil Kumar Joshi
Journal:  Front Mol Biosci       Date:  2019-10-18

9.  Biomarker profile in stable Fontan patients.

Authors:  Anita Saraf; Christine De Staercke; Ian Everitt; Alice Haouzi; Yi-An Ko; Staci Jennings; Jonathan H Kim; Fred H Rodriguez; Andreas P Kalogeropoulos; Arshed Quyyumi; Wendy Book
Journal:  Int J Cardiol       Date:  2020-01-09       Impact factor: 4.164

10.  Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model.

Authors:  Kristopher D Rawls; Bonnie V Dougherty; Kalyan C Vinnakota; Venkat R Pannala; Anders Wallqvist; Glynis L Kolling; Jason A Papin
Journal:  Toxicol Appl Pharmacol       Date:  2020-12-31       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.